Trial intelligence / Profile preview

Sertraline for HIV-Associated Cryptococcal Meningitis

NCT01802385Phase 3Completed

Sponsor
University of Minnesota
Start
Mar 2015
Primary completion
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sertraline in cryptococcal meningitis, sponsored by University of Minnesota. Started Mar 2015; status: completed.

02

Drugs

sertraline
03

Conditions

cryptococcal meningitis

Beyond the preview

Go deeper on NCT01802385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01802385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call